Hain Celestial sells Arrowhead Mills and SunSpire to Hometown Food Co.

Global organic chocolate market is witnessing a substantial growth due to the increasing health consciousness among customers as well as the growing demand of quality food. Owing to these reasons, the global food industry is witnessing vari....

Nine Entertainment attains 90% stake in radio group Macquarie Media

The media industry has become a very competitive space lately. Especially in today’s age where consumers crave quality content, small startups have turned out to be a serious contender in this sector. In order to stay ahead of th....

Nicox announces topline results from Glaucoma Dolomites Phase 2 Trial

Glaucoma is a disease that damages a patient’s optic nerve and can eventually lead to blindness if not treated on time. It is currently considered to be the third leading cause of irreversible blindness worldwide. The current treatmen....

Udaan raises $585Mn in a Series D investment round led by Tencent

India’s unicorn startup club has been inducting new members to its ranks at an unprecedented rate over the past couple of years. Recently, unicorns, private startups valued at US$1 billion or more, have been emerging into the market t....

iCAD exhibits ProFound AI™ platform for DBT at the EUSOBI in Budapest

Breast cancer is one of the most prominent cancer types that can occur in women. Though treatment options depend on the stage of the disease, it can be addressed successfully if diagnosed and treated early. Various medical and pharmaceutica....

ImmunoGen presents data from FORWARD II Triplet Cohort at ESMO

Ovarian cancer occurs when cells in the ovary start to mutate abnormally, further forming a tumor. At late stages, ovarian cancer can become difficult to treat and could also be fatal to patient. Several pharmaceutical firms are focusi....

GlaxoSmithKline presents the PRIMA study for first-line ovarian cancer

The treatment graph for one of the most fatal ailments of the 21st century, the dreaded ‘cancer’, seems to be on the verge of witnessing yet another variable addition. In what may seem as yet another stupendous effort by healthc....

Herantis Pharma releases update on timeline of its ongoing CDNF trial

Parkinson's disease (PD) is an incurable, progressive neurodegenerative disease which is caused by the death of dopaminergic neurons in the midbrain. With medication, motor symptoms can be treated but it is impossible to prevent the pro....

Incyte treats first patient in its Phase 3 ruxolitinib clinical trial

Vitiligo is a common disease that causes the patient to lose skin color in random blotches. The disease can affect any body part, even affecting the inside of the patient’s mouth and hair. There are some treatments that help in r....

Galapagos begins Phase 1 trial for second generation Toledo compound

Cases of inflammatory diseases are expected to increase in the near future, which is a major concern for people across the world. Various pharmaceutical companies as well as medical research organizations are increasingly working towards fi....